D3 (Tokyo) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
17
- Portfolio
-
9
- Exits
-
1
D3 (Tokyo) General Information
Company Description
D3 LLC is a private equity firm that is based in Tokyo, Japan. The firm prefers to invest in biotech and digital healthcare start-ups with tech and ideas.
Business Details
Website
www.d3growth.comInvestor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 18Floor Yebisu Garden Place Tower
- 4-20-3 Ebisu
- Tokyo, Shibuya 150-6018
- Japan
D3 (Tokyo) Investments (17)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| RevolKa | 18-Aug-2025 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| B4A (Enterprise Systems (Healthcare)) | 09-Jul-2025 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Alpha Fusion | 07-Oct-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Shinobi Therapeutics | 01-Aug-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Cyto-Facto | 31-Mar-2024 | Biotechnology | Generating Revenue | |||
| B4A (Enterprise Systems (Healthcare)) | 26-Sep-2023 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Cyto-Facto | 28-Aug-2023 | Biotechnology | Generating Revenue | |||
| iSiP | 22-Aug-2023 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Grace imaging | 05-Jul-2023 | Later Stage VC | Monitoring Equipment | Generating Revenue | ||
| Alpha Fusion | 12-Jun-2023 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
D3 (Tokyo) Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Thyas | 12-Dec-2023 |
D3 (Tokyo) Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
D3 (Tokyo) Investments by Industry, Year, and Region
D3 (Tokyo) Co-Investors (37)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| SBI Investment | 3 |
|
|
||
| DEEPCORE |
|
|
|||
| Eight Roads |
|
|
|||
| F-Prime |
|
|
|||
| Mitsubishi UFJ Capital |
|
|
D3 (Tokyo) FAQs
-
What is D3 (Tokyo)?
D3 LLC is a private equity firm that is based in Tokyo, Japan.
-
Where is D3 (Tokyo) headquartered?
D3 (Tokyo) is headquartered in Tokyo, Japan.
-
What is D3 (Tokyo)'s total asset value?
D3 (Tokyo) has around in total assets under management.
-
How many investments has D3 (Tokyo) made?
D3 (Tokyo) has made 17 investments.
-
What has D3 (Tokyo) invested in?
D3 (Tokyo) has made numerous investments in companies like RevolKa, B4A (Enterprise Systems (Healthcare)), and Alpha Fusion within the Drug Discovery and Enterprise Systems (Healthcare) industries.
-
What has D3 (Tokyo) invested in recently?
D3 (Tokyo)'s latest investment was on 18-Aug-2025 in RevolKa, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process